Bruker financials
$64.51+1.94%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Dec 31 | FY24 Dec 31 | FY23 Dec 31 | FY22 Dec 31 | FY21 Dec 31 | FY20 Dec 31 | FY19 Dec 31 | FY18 Dec 31 | FY17 Dec 31 | FY16 Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $3.44B | $3.37B | $2.96B | $2.53B | $2.42B | $1.99B | $2.07B | $1.90B | $1.77B | $1.61B |
| Gross profit | $1.58B | $1.65B | $1.51B | $1.31B | $1.21B | $939.8M | $995.3M | $900.0M | $816.0M | $745.3M |
| Gross margin | 45.9% | 49.0% | 51.0% | 51.6% | 50.0% | 47.3% | 48.0% | 47.5% | 46.2% | 46.3% |
| Operating income | $68.2M | $253.1M | $436.9M | $432.7M | $413.3M | $248.3M | $300.9M | $262.4M | $219.5M | $181.8M |
| Net income | -$22.5M | $113.1M | $427.2M | $296.6M | $277.1M | $157.8M | $197.2M | $179.7M | $78.6M | $153.6M |
| Net margin | −0.7% | 3.4% | 14.4% | 11.7% | 11.5% | 7.9% | 9.5% | 9.5% | 4.5% | 9.5% |
| Diluted EPS | $-0.15 | $0.76 | $2.90 | $1.99 | $1.81 | $1.02 | $1.26 | $1.14 | $0.49 | $0.95 |
| EBITDA | $385.0M | $436.9M | $551.8M | $551.2M | $516.7M | $353.6M | $383.0M | $346.8M | $303.1M | $261.9M |
| Operating cash flow | $134.1M | $251.3M | $350.1M | $274.4M | $282.4M | $332.2M | $213.4M | $239.7M | $154.4M | $130.8M |
| Free cash flow | $13.9M | $136.0M | $243.2M | $145.2M | $190.4M | $235.0M | $140.4M | $190.5M | $110.7M | $93.7M |
| Diluted shares | 151.8M | 149.5M | 147.2M | 149.4M | 152.9M | 154.6M | 156.6M | 157.2M | 159.1M | 162.2M |
Balance sheet
| Period end | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $298.8M | $183.4M | $488.3M | $645.5M | $1.07B | $681.8M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | $100.0M | $50.0M |
| Total debt | $1.87B | $2.09B | $1.28B | $1.22B | $1.33B | $844.5M |
| Total assets | $6.24B | $5.81B | $4.25B | $3.61B | $3.65B | $3.05B |
| Total liabilities | $3.73B | $3.99B | $2.84B | $2.48B | $2.57B | $2.07B |
| Shareholders' equity | $2.47B | $1.80B | $1.39B | $1.13B | $1.08B | $974.3M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology